GeneDx Holdings Corp - Ordinary Shares - Class A

NASDAQ:WGS 4:00:00 PM EDT

52.76

+2.94 (+5.90%)

5:02:25 PM EDT: $52.75 -0.01 (-0.02%)

Market Cap (Intraday)	1.42B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$64.98 Million
Adjusted EPS	-$0.26

See more estimates

10-Day MA	$45.39
50-Day MA	$36.00
200-Day MA	$19.90

See more pivots

GeneDx Holdings Corp - Ordinary Shares - Class A Stock, NASDAQ:WGS

North Tower, 333 Ludlow Street, Stamford, Connecticut 06902

United States of America

Phone: +1.888.729.1206

Number of Employees: 1000

http://www.genedx.com

Description

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.